Viehbacher Christopher

Viehbacher Christopher is listed in filings as President and CEO at Biogen Inc. This profile follows SEC Form 4 activity through Feb 17, 2026, including 10 public disclosures. Recent filings connect the profile to Biogen Inc (BIIB). The current snapshot covers public activity from Feb 10, 2025 to Feb 17, 2026. Reported amounts are shown as $1.3M to $605.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.